Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course
J. Muri, V. Cecchinato, A. Cavalli…·Franzetti-Pelland
The paper finds that anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease outcomes and predict absence of long COVID symptoms.